Search Results - "Howe, Louise"

Refine Results
  1. 1

    Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer by Howe, Louise R

    Published in Breast cancer research : BCR (16-07-2007)
    “…Many human cancers exhibit elevated prostaglandin (PG) levels due to upregulation of cyclooxygenase-2 (COX-2), a key enzyme in eicosanoid biosynthesis. COX-2…”
    Get full text
    Journal Article
  2. 2

    Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer by HOWE, Louise R, SUBBARAMAIAH, Kotha, HUDIS, Clifford A, DANNENBERG, Andrew J

    Published in Clinical cancer research (15-11-2013)
    “…The increasing rate of obesity worldwide is predicted to be associated with a surge in diseases. Notably, obesity has been linked to approximately 20% of…”
    Get full text
    Journal Article
  3. 3

    Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer by Iyengar, Neil M, Zhou, Xi Kathy, Gucalp, Ayca, Morris, Patrick G, Howe, Louise R, Giri, Dilip D, Morrow, Monica, Wang, Hanhan, Pollak, Michael, Jones, Lee W, Hudis, Clifford A, Dannenberg, Andrew J

    Published in Clinical cancer research (01-05-2016)
    “…Obesity, insulin resistance, and elevated levels of circulating proinflammatory mediators are associated with poorer prognosis in early-stage breast cancer. To…”
    Get full text
    Journal Article
  4. 4

    Identification of PADI2 as a potential breast cancer biomarker and therapeutic target by McElwee, John L, Mohanan, Sunish, Griffith, Obi L, Breuer, Heike C, Anguish, Lynne J, Cherrington, Brian D, Palmer, Ashley M, Howe, Louise R, Subramanian, Venkataraman, Causey, Corey P, Thompson, Paul R, Gray, Joe W, Coonrod, Scott A

    Published in BMC cancer (30-10-2012)
    “…We have recently reported that the expression of peptidylarginine deiminase 2 (PADI2) is regulated by EGF in mammary cancer cells and appears to play a role in…”
    Get full text
    Journal Article
  5. 5

    Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouse by Khalil, Sara, Tan, Grace A, Giri, Dilip D, Zhou, Xi Kathy, Howe, Louise R

    Published in PloS one (23-03-2012)
    “…Wnt/ß-catenin signaling is strongly implicated in neoplasia, but the role of this pathway in human breast cancer has been controversial. Here, we examined…”
    Get full text
    Journal Article
  6. 6

    Targeting the HER/EGFR/ErbB family to prevent breast cancer by Howe, Louise R, Brown, Powel H

    “…Preventing breast cancer is possible with selective estrogen receptor (ER) modulators and aromatase inhibitors, which reduce the risk of invasive disease by up…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Establishing estrogen-responsive mouse mammary organoids from single Lgr5 + cells by Zhang, Lixing, Adileh, Mohammad, Martin, Maria Laura, Klingler, Stefan, White, Julie, Ma, Xiaojing, Howe, Louise R, Brown, Anthony M C, Kolesnick, Richard

    Published in Cellular signalling (01-01-2017)
    “…Recent evidence suggests that mammary cells expressing R-spondin receptor and Wnt pathway regulator Lgr5, regarded as a stem cell marker in multiple tissues,…”
    Get full text
    Journal Article
  10. 10

    Wnt Signaling and Breast Cancer by Howe, Louise R., Brown, Anthony M.C.

    Published in Cancer biology & therapy (01-01-2004)
    “…Secreted signaling factors of the Wnt protein family regulate many cellular processes, including cell fate decisions and cell proliferation, and aberrant Wnt…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Cyclooxygenase-2-Derived Prostacyclin Regulates Arterial Thrombus Formation by Suppressing Tissue Factor in a Sirtuin-1―Dependent-Manner by BARBIERI, Silvia S, AMADIO, Patrizia, GIANELLINI, Sara, TARANTINO, Eva, ZACCHI, Elena, VEGLIA, Fabrizio, HOWE, Louise R, WEKSLER, Babette B, MUSSONI, Luciana, TREMOLI, Elena

    Published in Circulation (New York, N.Y.) (11-09-2012)
    “…Selective inhibitors of cyclooxygenase (COX)-2 increase the risk of myocardial infarction and thrombotic events, but the responsible mechanisms are not fully…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation by HOWE, Louise R, WATANABE, Osamu, LEONARD, James, BROWN, Anthony M. C

    Published in Cancer research (Chicago, Ill.) (15-04-2003)
    “…Wnt1, initially identified as a mammary oncogene, can activate transcription via beta-catenin/TCF complexes. Twist, a transcription factor of the basic…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer by Dannenberg, A J, Altorki, N K, Boyle, J O, Dang, C, Howe, L R, Weksler, B B, Subbaramaiah, K

    Published in The lancet oncology (01-09-2001)
    “…Understanding the mechanisms underlying carcinogenesis provides insights that are necessary for the development of therapeutic strategies to prevent cancer…”
    Get more information
    Journal Article
  18. 18

    HER-2/neu status is a determinant of mammary aromatase activity in vivo : Evidence for a cyclooxygenase-2-dependent mechanism by SUBBARAMAIAH, Kotha, HOWE, Louise R, PORT, Elisa R, BROGI, Edi, FISHMAN, Jack, LIU, Catherine H, HLA, Timothy, HUDIS, Clifford, DANNENBERG, Andrew J

    Published in Cancer research (Chicago, Ill.) (15-05-2006)
    “…Cytochrome P450 aromatase (aromatase), a product of the CYP19 gene, catalyzes the synthesis of estrogens from androgens. Given the significance of estrogen…”
    Get full text
    Journal Article
  19. 19

    Pea3 transcription factors and wnt1-induced mouse mammary neoplasia by Baker, Rebecca, Kent, Claire V, Silbermann, Rachel A, Hassell, John A, Young, Lawrence J T, Howe, Louise R

    Published in PloS one (22-01-2010)
    “…The role of the PEA3 subfamily of Ets transcription factors in breast neoplasia is controversial. Although overexpression of PEA3 (E1AF/ETV4), and of the…”
    Get full text
    Journal Article
  20. 20

    Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1 by Subbaramaiah, Kotha, Howe, Louise R, Zhou, Xi Kathy, Yang, Peiying, Hudis, Clifford A, Kopelovich, Levy, Dannenberg, Andrew J

    “…Estrogen synthesis is catalyzed by cytochrome P450 aromatase, which is encoded by the CYP19 gene. In obese postmenopausal women, increased aromatase activity…”
    Get full text
    Journal Article